Sangamo Therapeutics (SGMO) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Revenue Growth %: -5.7%
Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: -5.7%
Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q2 EPS of ($0.18), $0.03 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $6.88 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Huntington Ingalls wins $418M Navy contract
- Getty Images strikes multi-year display deal with OpenAI for ChatGPT
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
